ibandronic acid
PolandDrugs containing this active substance
-
The medicine is used for the treatment of postmenopausal osteoporosis. It helps to inhibit bone loss, increase bone mass, and reduce the risk of vertebral fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid 150 mg ATC: M05BA06
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used for the treatment of postmenopausal osteoporosis. It helps to inhibit bone loss, increase bone mass, and reduce the risk of bone fractures (especially vertebrae).
Form: tablets, film-coated
Active substance Dosage ibandronic acid 150 mg ATC: M05BA06
Manufacturer: APL Swift Services (Malta) Ltd.
-
The medicine is used in adults with breast cancer that has spread to the bones, to prevent fractures and complications requiring surgery or radiation. It is also used when the cancer causes high calcium levels in the blood.
Form: solution for infusion, concentrate
Active substance Dosage ibandronic acid 6,414 mg ATC: M05BA06
Manufacturer: Demo S.A.